PT1423102E - Emplastro para o tratamento de disfunções e perturbações o crescimento da unha - Google Patents

Emplastro para o tratamento de disfunções e perturbações o crescimento da unha Download PDF

Info

Publication number
PT1423102E
PT1423102E PT02797674T PT02797674T PT1423102E PT 1423102 E PT1423102 E PT 1423102E PT 02797674 T PT02797674 T PT 02797674T PT 02797674 T PT02797674 T PT 02797674T PT 1423102 E PT1423102 E PT 1423102E
Authority
PT
Portugal
Prior art keywords
treatment
nail
dysfunctions
disorders
plasters
Prior art date
Application number
PT02797674T
Other languages
English (en)
Inventor
Rudy Susilo
Original Assignee
Trommsdorff Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trommsdorff Arzneimittel filed Critical Trommsdorff Arzneimittel
Publication of PT1423102E publication Critical patent/PT1423102E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT02797674T 2001-09-04 2002-09-04 Emplastro para o tratamento de disfunções e perturbações o crescimento da unha PT1423102E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01121202 2001-09-04

Publications (1)

Publication Number Publication Date
PT1423102E true PT1423102E (pt) 2008-02-25

Family

ID=8178546

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02797674T PT1423102E (pt) 2001-09-04 2002-09-04 Emplastro para o tratamento de disfunções e perturbações o crescimento da unha

Country Status (22)

Country Link
US (1) US20040265362A1 (pt)
EP (1) EP1423102B1 (pt)
JP (1) JP4806162B2 (pt)
KR (1) KR100757611B1 (pt)
CN (1) CN1703206A (pt)
AU (1) AU2002361825B2 (pt)
BR (1) BR0212304A (pt)
CA (1) CA2459483C (pt)
CY (1) CY1107284T1 (pt)
CZ (1) CZ301310B6 (pt)
DE (1) DE60223694T2 (pt)
DK (1) DK1423102T3 (pt)
ES (1) ES2299630T3 (pt)
IL (2) IL160550A0 (pt)
MX (1) MXPA04001833A (pt)
NO (1) NO20040936L (pt)
NZ (1) NZ531406A (pt)
PL (1) PL205576B1 (pt)
PT (1) PT1423102E (pt)
RU (1) RU2302857C2 (pt)
WO (1) WO2003020250A1 (pt)
ZA (1) ZA200401445B (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100757611B1 (ko) * 2001-09-04 2007-09-10 트롬스도르프 게엠베하 운트 코. 카게 알츠나이미텔 손발톱 성장의 기능장애와 질환을 치료하기 위한 플라스터
US7615238B2 (en) * 2001-09-04 2009-11-10 Trommsdorff GmbH & Co. KG Arzneimitttel Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole
FR2867978B1 (fr) * 2004-03-29 2009-02-20 Galderma Res & Dev Patch d'amorolfine pour le traitement de l'onychomicose
JP4992181B2 (ja) * 2004-12-28 2012-08-08 大正製薬株式会社 外用剤組成物
EP1893159B1 (en) 2005-06-17 2015-09-30 Vital Health Sciences Pty Ltd. A carrier comprising one or more di- and/or monophosphate derivatives of electron transfer agents
JP4861420B2 (ja) * 2006-08-28 2012-01-25 久光製薬株式会社 爪用貼付剤
WO2008105038A1 (ja) * 2007-02-23 2008-09-04 Nichiban Company Limited 抗真菌症用貼付剤
EP3441054B1 (en) * 2007-11-05 2020-08-05 Abigo Medical Ab Device for the treatment of vaginal fungal infection
US8263115B2 (en) * 2008-09-11 2012-09-11 Abigo Medical Ab Method and a product to reduce and treat problems associated with tinea pedis
US10893983B2 (en) 2008-12-03 2021-01-19 Abigo Medical Ab Method for dressing a wound
WO2011079234A2 (en) 2009-12-23 2011-06-30 Nuvo Research Inc. Highly permeating terbinafine formulation
US8574621B2 (en) 2010-02-05 2013-11-05 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch for treatment of tinea unguium
WO2011094814A1 (en) 2010-02-05 2011-08-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
DK2547323T3 (en) 2010-03-17 2016-05-02 Novaliq Gmbh PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INCREASED INTRAOCULAR PRESSURE
MX2012011355A (es) 2010-03-30 2012-11-30 Phosphagenics Ltd Parche de suministro transdermico.
EP2462921A1 (en) 2010-11-11 2012-06-13 Novaliq GmbH Liquid pharmaceutical compositions for the treatment of a posterior eye disease
US9561243B2 (en) 2011-03-15 2017-02-07 Phosphagenics Limited Composition comprising non-neutralised tocol phosphate and a vitamin A compound
RU2483748C2 (ru) * 2011-04-15 2013-06-10 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая инсулин и липосомы, для местного применения в виде пластыря
RU2483749C2 (ru) * 2011-04-15 2013-06-10 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая инсулин и липосомы, для местного применения в виде биопленки
CA2834862C (en) * 2011-05-25 2019-12-17 Novaliq Gmbh Pharmaceutical composition for administration to nails
CN108283623A (zh) 2011-05-25 2018-07-17 诺瓦利克有限责任公司 基于半氟化烷烃类的外用药物组合物
DK2806886T3 (en) 2012-01-23 2017-06-06 Novaliq Gmbh STABILIZED PROTEIN COMPOSITIONS BASED ON SEMIFLUORED ALKANES
ES2621226T3 (es) 2012-09-12 2017-07-03 Novaliq Gmbh Composiciones de alcanos semifluorados
EP3100722B1 (en) 2012-09-12 2024-03-20 Novaliq GmbH Semifluorinated alkanes for use in solubilizing meibum
WO2015011199A1 (en) 2013-07-23 2015-01-29 Novaliq Gmbh Stabilized antibody compositions
ES2743502T3 (es) 2015-09-30 2020-02-19 Novaliq Gmbh Compuestos semifluorados y sus composiciones
US11154513B2 (en) 2015-09-30 2021-10-26 Novaliq Gmbh Semifluorinated compounds
AU2016367708B2 (en) 2015-12-09 2022-07-14 Phosphagenics Limited Pharmaceutical formulation
PT3442480T (pt) 2016-06-23 2019-12-23 Novaliq Gmbh Método de administração tópica
CA3036297C (en) 2016-09-22 2023-09-05 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis
KR20190057338A (ko) 2016-09-23 2019-05-28 노바리크 게엠베하 시클로스포린을 포함하는 안과 조성물
KR102647670B1 (ko) 2016-12-21 2024-03-15 아베초 바이오테크놀로지 리미티드 방법
ES2957559T3 (es) 2017-04-21 2024-01-22 Dermaliq Therapeutics Inc Composiciones de yodo
EP3621601A1 (en) 2017-05-12 2020-03-18 Novaliq GmbH Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions
IL273531B2 (en) 2017-09-27 2024-05-01 Novaliq Gmbh Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases
US11896559B2 (en) 2017-10-04 2024-02-13 Novaliq Gmbh Opthalmic compositions comprising F6H8
EP3758676A1 (en) 2018-03-02 2021-01-06 Novaliq GmbH Pharmaceutical compositions comprising nebivolol
DE102018115270B4 (de) * 2018-06-26 2022-07-14 Vinederm GmbH Zubereitung als Gel und Pflaster zur topischen Behandlung von Haut- und/oder Nagelerkrankungen
US11510855B2 (en) 2018-09-27 2022-11-29 Dermaliq Therapeutics, Inc. Topical sunscreen formulation
US12029757B2 (en) 2018-09-27 2024-07-09 Dermaliq Therapeutics, Inc. Lipid barrier repair
SG11202102820VA (en) 2018-10-12 2021-04-29 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease
RU2717086C1 (ru) * 2019-01-31 2020-03-18 Федеральное государственное бюджетное учреждение науки Ордена Трудового Красного Знамени Институт нефтехимического синтеза им. А.В. Топчиева Российской академии наук (ИНХС РАН) Способ получения основы для пластырей и гелей (варианты)
RU2769437C1 (ru) * 2021-07-08 2022-03-31 Светлана Николаевна Абрамова Способ восстановления роста ногтя

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5181914A (en) * 1988-08-22 1993-01-26 Zook Gerald P Medicating device for nails and adjacent tissue
US5464610A (en) * 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
US5861142A (en) * 1996-03-25 1999-01-19 Schick; Mary Pichler Method for promoting hair, nail, and skin keratinization
JP2001502317A (ja) * 1996-10-16 2001-02-20 アイ・ピー・アール・インシティチュート・フォー・ファーマシューティカル・リサーチ・エー・ジー 新規なキャリヤー系
US6727401B1 (en) * 1998-02-12 2004-04-27 Watson Pharmaceuticals, Inc. Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
CA2343284C (en) * 1998-09-10 2008-11-18 Ipr-Institute For Pharmaceutical Research Ag Topical application products
US6303140B1 (en) * 1999-10-13 2001-10-16 Schering-Plough Healthcare Products, Inc. Medicated device for warts, corns, calluses and nails
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
KR100757611B1 (ko) * 2001-09-04 2007-09-10 트롬스도르프 게엠베하 운트 코. 카게 알츠나이미텔 손발톱 성장의 기능장애와 질환을 치료하기 위한 플라스터

Also Published As

Publication number Publication date
EP1423102A1 (en) 2004-06-02
JP4806162B2 (ja) 2011-11-02
KR100757611B1 (ko) 2007-09-10
EP1423102B1 (en) 2007-11-21
ZA200401445B (en) 2005-03-10
ES2299630T3 (es) 2008-06-01
PL205576B1 (pl) 2010-05-31
DE60223694D1 (de) 2008-01-03
AU2002361825B2 (en) 2007-01-25
NO20040936D0 (no) 2004-03-03
DK1423102T3 (da) 2008-04-14
CA2459483C (en) 2009-06-23
NO20040936L (no) 2004-06-04
NZ531406A (en) 2006-03-31
MXPA04001833A (es) 2004-07-08
IL160550A0 (en) 2004-07-25
RU2302857C2 (ru) 2007-07-20
BR0212304A (pt) 2004-10-13
RU2004106780A (ru) 2005-04-20
CY1107284T1 (el) 2012-11-21
CA2459483A1 (en) 2003-03-13
JP2005501885A (ja) 2005-01-20
IL160550A (en) 2010-11-30
CZ301310B6 (cs) 2010-01-13
CZ2004317A3 (cs) 2004-10-13
US20040265362A1 (en) 2004-12-30
WO2003020250A1 (en) 2003-03-13
PL367513A1 (en) 2005-02-21
KR20040031046A (ko) 2004-04-09
DE60223694T2 (de) 2008-10-30
CN1703206A (zh) 2005-11-30

Similar Documents

Publication Publication Date Title
IL160550A (en) Plaster for the treatment of dysfunctions and disorders of nail growth
IL160552A0 (en) Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole
SE9803239D0 (sv) Composition for the treatment of acute pain
NZ520015A (en) Hydroxide-releasing agents as skin permeation enhancers
WO2003047503A3 (en) Delivery of medicaments to the nail
MXPA05006359A (es) Tratamiento de la enfermedad a traves de inhibidores peptidos antimicrobianos.
ATE347871T1 (de) Vorgeformte folie zur topischen anwendung
ID26791A (id) Formulasi untuk pencegahan atau perlakuan penyakit yang mempengaruhi mukosa atau kulit, atau untuk pencegahan kehamilan dan alat pemakai terhadap pengiriman formulasi topikal didalam rongga-rongga mukosal
HUP0203529A2 (hu) Dezloratadin alkalmazása alvászavarok kezelésére
NZ526806A (en) Therapeutic film forming composition and treatment system
AU2001246600A1 (en) Use of comt inhibitors as analgesics
DE50108168D1 (de) Transdermales therapeutisches system zur abgabe von lerisetron
PL367514A1 (en) Plaster for the treatment of dysfunctions and disorders of nails
IL160551A (en) Plaster for the treatment of dysfunctions and disorders of nails